ClearPoint Neuro, Inc.
CLPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9 | $9 | $8 | $8 |
| % Growth | -3.8% | 8.6% | 9.2% | – |
| Cost of Goods Sold | $3 | $4 | $3 | $3 |
| Gross Profit | $6 | $6 | $5 | $5 |
| % Margin | 63.2% | 60.3% | 60.5% | 61.3% |
| R&D Expenses | $3 | $4 | $3 | $3 |
| G&A Expenses | $3 | $3 | $4 | $3 |
| SG&A Expenses | $7 | $7 | $8 | $7 |
| Sales & Mktg Exp. | $4 | $4 | $4 | $4 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $11 | $11 | $10 |
| Operating Income | -$5 | -$6 | -$6 | -$6 |
| % Margin | -59.5% | -61.6% | -72.6% | -72.1% |
| Other Income/Exp. Net | -$1 | -$0 | $0 | $0 |
| Pre-Tax Income | -$6 | -$6 | -$6 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$6 | -$6 | -$5 |
| % Margin | -66.5% | -63.3% | -71% | -69.3% |
| EPS | -0.21 | -0.21 | -0.22 | -0.2 |
| % Growth | 0% | 4.5% | -10% | – |
| EPS Diluted | -0.21 | -0.21 | -0.22 | -0.2 |
| Weighted Avg Shares Out | 28 | 28 | 28 | 27 |
| Weighted Avg Shares Out Dil | 28 | 28 | 28 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $0 |
| EBITDA | -$5 | -$5 | -$6 | -$5 |
| % Margin | -59.5% | -55.4% | -68.7% | -66.1% |